Publications by authors named "Jennifer M Matro"

Claim this Profile
R
Ruxolitinib and exemestane for estrogen receptor positive, aromatase inhibitor resistant advanced breast cancer.
Igor Makhlin, Nicholas P McAndrew, E Paul Wileyto, Amy S Clark, Robin Holmes, Jennifer M Matro

NPJ Breast Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refining the indications for neoadjuvant chemotherapy for patients with HER2+ breast cancer: A single institution experience.
Maria K Pomponio, Laura Burkbauer, Macy Goldbach, Susanna M Nazarian, Fei Xie, Jennifer M Matro

J Surg Oncol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does time to adjuvant chemotherapy (TTC) affect outcomes in patients with triple-negative breast cancer?
Maria K Pomponio, Luke J Keele, Kevin R Fox, Amy S Clark, Jennifer M Matro

Breast Cancer Res Treat· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Intratumoral Injections of Chimeric Antigen Receptor (CAR) T Cells in Metastatic Breast Cancer.
Julia Tchou, Yangbing Zhao, Bruce L Levine, Paul J Zhang, Megan M Davis, Jennifer M Matro

Cancer Immunol Res· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying patients at high risk of breast cancer recurrence: strategies to improve patient outcomes.
Yehoda M Martei, Jennifer M Matro

Breast Cancer (Dove Med Press)· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory breast cancer management in the national comprehensive cancer network: the disease, recurrence pattern, and outcome.
Jennifer M Matro, Tianyu Li, Massimo Cristofanilli, Melissa E Hughes, Rebecca A Ottesen

Clin Breast Cancer· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost sharing and hereditary cancer risk: predictors of willingness-to-pay for genetic testing.
Jennifer M Matro, Karen J Ruth, Yu-Ning Wong, Katen C McCully, Christina M Rybak

J Genet Couns· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How do I follow patients with early breast cancer after completing adjuvant therapy.
Jennifer M Matro, Lori J Goldstein

Curr Treat Options Oncol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys.
Joseph E Blaney, Jennifer M Matro, Brian R Murphy, Stephen S Whitehead

J Virol· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis